Doximity, Inc. (DOCS)
$25.30-0.12%Close
SELLRECOVERY · day 49
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $4.7B
- Avg volume
- 4.9M
- Beta
- 1.21
- P/E (TTM)
- 28.43
- Short % float
- 13.55%
- Days to cover
- 8.0
- SI change
- +18.5%
- 1W
- +3.18%
- 1M
- +23.90%
- 3M
- +26.88%
- YTD
- -41.56%
- vs SPY 1W
- +4.37%
- vs SPY 1M
- +20.58%
- vs SPY 3M
- +24.49%
- vs SPY YTD
- -53.31%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- TCMDSELLTactile Systems Technology, Inc.CRISISQ 13$23.36-1.93%
- LKFTBUYRECOVERYQ 8$29.04+0.83%
- OPRXBUYOptimizeRx CorporationRECOVERYQ 10$7.65-0.78%
- ELTPSELLElite Pharmaceuticals, Inc.CRISISQ 5$0.29+0.00%
- PLXSELLProtalix BioTherapeutics, Inc.RECOVERYQ 4$2.41+1.26%
- ZVRABUYZevra Therapeutics, Inc.RECOVERYQ -7$11.65-1.85%
- GMEDBUYGlobus Medical, Inc.RECOVERYQ 23$84.08-3.26%
- PODDSELLInsulet CorporationRECOVERYQ 17$145.42-1.85%
- CPRXBUYCatalyst Pharmaceuticals, Inc.BULLQ 20$31.49+0.00%
- MDTBUYMedtronic plcRECOVERYQ 12$92.90-0.48%
- ABUSBUYArbutus Biopharma CorporationRECOVERYQ 13$5.20-0.19%
- NAGESELLNiagen Bioscience IncRECOVERYQ 11$3.21+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- GHBUYGuardant Health, Inc.$21.5BBULLQ 23$160.12-4.40%
- EXASExact Sciences Corporation$20.0B$104.91
- VTRSSELLViatris Inc.$18.8BBEARQ 4$16.17+1.35%
- SOLVBUYSolventum Corporation$15.1BBULLQ 16$87.45+1.88%
- COOBUYThe Cooper Companies, Inc.$14.8BRECOVERYQ 17$75.76-0.55%
- ICLRBUYICON Public Limited Company$12.8BRECOVERYQ 18$167.05+0.73%
- RVTYBUYRevvity, Inc.$12.7BBULLQ 10$113.75-1.40%
- EHCBUYEncompass Health Corporation$12.1BBULLQ 15$122.10+0.51%
- TEMBUYTempus AI, Inc.$8.6BRECOVERYQ 27$49.36-8.97%
- HQYBUYHealthEquity, Inc.$8.6BBULLQ 17$102.79-0.01%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 39
- VALUE
- 32
- GROWTH
- 66
- GARP
- 19
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC10.2%
REV YoY-
ROE6.3%
EPS YoY-
ROA15.4%
GROSS88
OP30
NET25
[VALUATION]
P/E TTM28.43
P/E FWD-
SECTOR PE22.62
INDUSTRY PE28.11
P/B5.04
P/FCF-
EV/EBITDA18.33
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.06
ALTMAN Z-
CURR RATIO6.08
ND/EBITDA-
BETA1.21



















